Fundraising FoxAnimal Cell Therapies
San Diego, US · Founded 2008 · Delaware corporation
Find your way into Animal Cell Therapies
Sign up to see every warm intro you have to Animal Cell Therapies
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Animal Cell Therapies team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
AI
Adam IrvingExecutive
KJ
Kathryn J. PetrucciNamed on SEC filing
Board
SB
Shaun BishopBoard director
GM
Gary M. PetrucciBoard director
RC
Roger C. KuhnBoard director
SA
Stephen A. de KanterBoard director
NT
Nikolai TankovichBoard director
Reported raises · per SEC filings
Form D private placements$9.1M disclosed across 4 rounds · 2012–2016
▶$5.6MraisedJul 2019 · 64 investors · BiotechnologyRule 506(b)
▶$5.6MraisedJul 2019 · 64 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Roger C. KuhnDirector
- Kathryn J. PetrucciExecutive Officer, Director, Promoter
- Gary M. PetrucciDirector
- Shaun BishopDirector
- Steve SimonDirector
- Dean SpatzDirector
- Offering amount
- $10M
- Amount sold
- $5.6M
- Proceeds to insiders
- $100K
- First sale
- Mar 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$37.5KraisedFeb 2015 · 1 investors · BiotechnologyRule 506(b)
▶$37.5KraisedFeb 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gary M. PetrucciDirector
- Kathryn J. PetrucciExecutive Officer, Director, Promoter
- Roger C. KuhnDirector
- Shaun BishopDirector
- Offering amount
- $1.4M
- Amount sold
- $37.5K
- Proceeds to insiders
- $100K
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3.1MraisedJan 2015 · 54 investors · BiotechnologyRule 506(b)
▶$3.1MraisedJan 2015 · 54 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kathryn J. PetrucciExecutive Officer, Director, Promoter
- Shaun BishopDirector
- Gary M. PetrucciDirector
- Roger C. KuhnDirector
- Offering amount
- $3.1M
- Amount sold
- $3.1M
- Proceeds to insiders
- $100K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$375KraisedFeb 2012 · 4 investors · BiotechnologyRule 506(b)
▶$375KraisedFeb 2012 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Adam IrvingExecutive Officer, Director
- Stephen A. de KanterDirector
- Roger C. KuhnDirector
- Kathryn J. PetrucciExecutive Officer, Director, Promoter
- Nikolai TankovichDirector
- Gary M. PetrucciDirector
- Offering amount
- $5.5M
- Amount sold
- $375K
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2008
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Animal Cell Therapies raised?
- Animal Cell Therapies has disclosed $9.1M raised across 4 rounds.
- Where is Animal Cell Therapies headquartered?
- Animal Cell Therapies is headquartered in San Diego, US.